The rising use of GLP-1 receptor agonists for diabetes, obesity, and potentially hepatology conditions like MASH has revealed concerns about their impact on gastroenterology, particularly regarding gastric emptying and bowel motility. These effects could interfere with endoscopic procedures, increasing risks such as aspiration and poor bowel preparation. Current guidelines suggest pausing GLP-1 RAs for a week before procedures to mitigate these risks, as highlighted in the latest issue of the Qazi Corner newsletter.
Keep Reading
Add A Comment